NCT03326310 2025-12-29Selumetinib and Azacitidine in High Risk Chronic Blood CancersUniversity of ChicagoPhase 1 Recruiting18 enrolled
NCT01290302 2025-06-12Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaAmerican Regent, Inc.Phase 1 Completed38 enrolled 14 charts
NCT01460498 2020-03-05Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)M.D. Anderson Cancer CenterPhase 1 Completed3 enrolled
NCT01110473 2017-11-20ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesAbbViePhase 1 Completed52 enrolled
NCT00351975 2014-12-23Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesNational Cancer Institute (NCI)Phase 1 Completed56 enrolled